SARS‐CoV‐2 and myasthenia

descriptionPublicationkeyboard_double_arrow_right Article 28 Jan 2021 English Publisher:WileyJournal:Journal of Medical Virology, volume 93, pages 4,133-4,135 (issn: 0146-6615, eissn: 1096-9071,

Copyright policy )

Authors: Finsterer, Josef; Scorza, Fulvio A.; Scorza, Carla A.; Fiorini, Ana C.;

doi: 10.1002/jmv.26501

pmid: 32910499

SARS‐CoV‐2 and myasthenia

- Summary
- Subjects
- Metrics

Abstract

The COVID-19 pandemic due to infection with SARS-CoV-2 not only affects political, economic, social, and cultural life, but also has a significant impact on medicine. This article is protected by copyright. All rights reserved.

Related Organizations

Universidade de São Paulo
Brazil
Pontifícia Universidade Católica de São Paulo
Brazil
UNIVERSIDADE DE SAO PAULO
Brazil
Pontifícia Universidade Católica de Goiás
Brazil

Keywords

Adult, Aged, 80 and over, Male, SARS-CoV-2, COVID-19, Cross Reactions, Middle Aged, Antibodies, Viral, Epitopes, Immunocompromised Host, Infectious Diseases, Muscular Diseases, Virology, Myasthenia Gravis, Humans, Female, Receptors, Cholinergic, Aged

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average